News
Search here results
search-total-matching73search-total-matching- TB immune response discovery could significantly reduce disease harm | MyAV·¶ News - MyAV·¶ – University College London
- UK variant, B.1.1.7, does not increase disease severity in hospitalised patients | MyAV·¶ News - MyAV·¶ – University College London
- Single dose of vaccine acts as ‘booster’ in those with prior COVID-19 infection | MyAV·¶ News - MyAV·¶ – University College London
- Significant new SARS-CoV-2 variants may emerge during chronic infection | MyAV·¶ News - MyAV·¶ – University College London
- Novel antiviral drug significantly more potent against SARS-CoV-2 | MyAV·¶ News - MyAV·¶ – University College London
- Analysis: Big data can help doctors predict which Covid patients will become seriously ill | MyAV·¶ News - MyAV·¶ – University College London
- Threats of new SARS-CoV-2 variants focus of UK-wide study | MyAV·¶ News - MyAV·¶ – University College London
- COVID-19: Online tool identifies patients at highest risk of deterioration | MyAV·¶ News - MyAV·¶ – University College London
- Scientists build whole functioning thymus from human cells | MyAV·¶ News - MyAV·¶ – University College London
- MyAV·¶ scientist elected President of the Academy of Medical Sciences | MyAV·¶ News - MyAV·¶ – University College London
Please enable JavaScript to use this page or